Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection

BACKGROUND: Rapid and sensitive diagnostic assays for SARS-CoV-2 detection are required for prompt patient management and infection control. The analytical and clinical performances of LightMix® Modular SARS and Wuhan CoV E-gene kit, a widely used commercial assay for SARS-CoV-2 detection, have not...

Descripción completa

Detalles Bibliográficos
Autores principales: Yip, Cyril Chik-Yan, Sridhar, Siddharth, Cheng, Andrew Kim-Wai, Leung, Kit-Hang, Choi, Garnet Kwan-Yue, Chen, Jonathan Hon-Kwan, Poon, Rosana Wing-Shan, Chan, Kwok-Hung, Wu, Alan Ka-Lun, Chan, Helen Shuk-Ying, Chau, Sandy Ka-Yee, Chung, Tom Wai-Hin, To, Kelvin Kai-Wang, Tsang, Owen Tak-Yin, Hung, Ivan Fan-Ngai, Cheng, Vincent Chi-Chung, Yuen, Kwok- Yung, Chan, Jasper Fuk-Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255195/
https://www.ncbi.nlm.nih.gov/pubmed/32516739
http://dx.doi.org/10.1016/j.jcv.2020.104476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255195/
https://www.ncbi.nlm.nih.gov/pubmed/32516739
http://dx.doi.org/10.1016/j.jcv.2020.104476

Ejemplares similares